Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Metabolic Complications of Glucocorticoid Excess
NCT01319994Phase 3Completed
- Sponsor
- Barts Health NHS Trust
- Start
- Jul 2012
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of metformin in iatrogenic Cushing's syndrome (iCS), sponsored by Barts Health NHS Trust. Started Jul 2012; status: completed.
02
Drugs
metformin
03
Conditions
iatrogenic Cushing's syndrome (iCS)
Beyond the preview
Go deeper on NCT01319994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01319994.